formerly Prospect.

Company Information

Orphai Therapeutics - A Subsidiary of Quince Therapeutics

Website

https://www.orphai-therapeutics.com

Employee count

11

Industry

Biotechnology Research

Headquarter

New Haven, Connecticut, United States

Employees

Bradley Parry, PhD

Head of Artificial Intelligence

David Scheer

Chairman of the Board

Candace Fuchs

Head Of Clinical Operations

Peter R. Young

Chief Scientific Officer

Isabelle M. Gorrillot

Consulting Chief Innovation Officer

Frequently Asked Questions About Orphai Therapeutics - A Subsidiary of Quince Therapeutics

Product

DataIntegrationsSecurityWorkflow

Get the app

Download Extension

© 2014 - 2026 Neuron. All rights reserved.